EDGAR Filing Documents for 0001104659-24-060689

Form 8-K - Current report:

SEC Accession No. 0001104659-24-060689

Filing Date

2024-05-13

Accepted

2024-05-13 17:26:55

Documents

Period of Report

2024-05-10

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm2414315d1_8k.htm iXBRL	8-K	42240
2	EXHIBIT 4.1	tm2414315d1_ex4-1.htm	EX-4.1	98034
3	EXHIBIT 4.2	tm2414315d1_ex4-2.htm	EX-4.2	92430
4	EXHIBIT 5.1	tm2414315d1_ex5-1.htm	EX-5.1	9940
5	EXHIBIT 10.1	tm2414315d1_ex10-1.htm	EX-10.1	95853
6	EXHIBIT 10.2	tm2414315d1_ex10-2.htm	EX-10.2	199195
7	EXHIBIT 99.1	tm2414315d1_ex99-1.htm	EX-99.1	10722
11	GRAPHIC	image_001.jpg	GRAPHIC	4201
	Complete submission text file	0001104659-24-060689.txt		870465

Data Files

Seq	Description	Document	Type	Size
8	XBRL TAXONOMY EXTENSION SCHEMA	fwbi-20240510.xsd	EX-101.SCH	3027
9	XBRL TAXONOMY EXTENSION LABEL LINKBASE	fwbi-20240510_lab.xml	EX-101.LAB	34240
10	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	fwbi-20240510_pre.xml	EX-101.PRE	22367
23	EXTRACTED XBRL INSTANCE DOCUMENT	tm2414315d1_8k_htm.xml	XML	3686

Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431

Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020

First Wave BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)